ArticleCancer cell2022

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.

Amin H Nassar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.